ClassID:

95199 āŽ˜

C07D333/62 - CPC Classification

Classification description:

Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems; Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring

Sub-classes:
Recent Application in this class:
#1
20240400502
2024-12-05

SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME

#2
20240254078
2024-08-01

Small molecule compounds having naphthylamine structure and application thereof

#3
20230348384
2023-11-02

Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides

#4
20220396581
2022-12-15

COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS

#5
20220396559
2022-12-15

N-((1,2,3.5,6,7-HEXAHYDRO-S-INDACEN-4-YL)CARBAMOYL)-4, 5, 6, 7-TETRAHYDROBENZOFURAN -2-SULFONAMIDE DERIVATIVES AND RELATED COMPOUNDS AS NLPR3 MODULATORS FOR THE TREATMENT OF MULTIPLE SCLEROSIS (MS)

#6
20220356205
2022-11-10

METHOD FOR PRODUCING AROMATIC ASTATINE COMPOUND

#7
20220127227
2022-04-28

Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides

#8
20220112159
2022-04-14

Sulfonylureas and related compounds and use of same

#9
20220054451
2022-02-24

2,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) inhibitors

#10
20220048858
2022-02-17

Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides

#11
20210115007
2021-04-22

glucosyl transferase inhibitors for dental caries therapy

#12
20210053915
2021-02-25

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

#13
20200087253
2020-03-19

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

#14
20190359564
2019-11-28

Sulfonylureas and related compounds and use of same

#15
20190345104
2019-11-14

Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides

#16
20190337918
2019-11-07

Benzo[b]thiophene compounds as STING agonists

#17
20190337917
2019-11-07

Benzo[b]thiophene compounds as STING agonists

#18
20190263775
2019-08-29

Glucosylceramide synthase inhibitors for the treatment of diseases

#19
20190144380
2019-05-16

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

#20
20180244610
2018-08-30

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

#21
20180230102
2018-08-16

Carboxy substituted (hetero) aromatic ring derivatives and preparation method and uses thereof

#22
20180093964
2018-04-05

Benzo[b]thiophene compounds as sting agonists

#23
20180044287
2018-02-15

Sulfonylureas and related compounds and use of same

#24
20170305847
2017-10-26

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

#25
20170283429
2017-10-05

Compounds for the treatment of paramyxovirus viral infections

#26
20170022154
2017-01-26

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

#27
20160229830
2016-08-11

Glucosylceramide synthase inhibitors for the treatment of diseases

#28
20160221938
2016-08-04

Bisarylsulfonamides useful in the treatment of inflammation and cancer

#29
20160096817
2016-04-07

Treatment of inflammatory bowel disease

#30
20160002187
2016-01-07

Apoptosis-inducing agent for the treatment of cancer and immune and autoimmune diseases

#31
20160002156
2016-01-07

-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

#32
20150329518
2015-11-19

Therapeutic prostaglandin receptor agonists

#33
20150266893
2015-09-24

Fused ring analogues of anti-fibrotic agents

#34
20150238498
2015-08-27

Compounds for the treatment of paramoxyvirus viral infections

#35
20150152080
2015-06-04

BENZOTHIOPHENE SULFONAMIDES DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS

#36
20150025068
2015-01-22

Bisarylsulfonamides useful in the treatment of inflammation and cancer

#37
20150018400
2015-01-15

Treatment of inflammatory bowel disease

#38
20140336396
2014-11-13

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

#39
20140235702
2014-08-21

Small molecule inhibitors of Mcl-1 and the uses of thereof

#40
20140107160
2014-04-17

CCR9 inhibitors and methods of use thereof

#41
20140024608
2014-01-23

INHIBITORS OF HISTONE DEACETYLASE AND PRODRUGS THEREOF

#42
20130338151
2013-12-19

Fused ring analogues of anti-fibrotic agents

#43
20130184278
2013-07-18

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

#44
20130172339
2013-07-04

Sulfonamide compounds

#45
20130005767
2013-01-03

THERAPEUTIC COMPOUNDS

#46
20120270863
2012-10-25

FUSED RING ANALOGUES OF ANTI-FIBROTIC AGENTS

#47
20120149688
2012-06-14

Platelet ADP receptor inhibitors

#48
20120129816
2012-05-24

Aryl sulfonamide amine compounds and their use as 5-HT6 ligands

#49
20120015990
2012-01-19

TASPASE1 inhibitors and their uses

#50
20110313000
2011-12-22

CCR9 inhibitors and methods of use thereof

#51
20110306614
2011-12-15

N-Hydroxylsulfonamide Derivatives as New Physiologically Useful Nitroxyl Donors

#52
20110213119
2011-09-01

Fused ring compound, method for producing the same, polymer, organic thin film containing the compound and/or polymer, and organic thin film device and organic thin film transistor each comprising the organic thin film

#53
20110172435
2011-07-14

Geminal dialkyl prostanoids

#54
20110092578
2011-04-21

Broad spectrum gram-positive antimicrobials and anthelmintics with efficacy against drug-resistant strains and species

#55
20110086852
2011-04-14

Pharmaceutical compounds

#56
20110065895
2011-03-17

FUSED RING COMPOUND, METHOD FOR PRODUCING THE SAME, POLYMER, ORGANIC THIN FILM CONTAINING THE COMPOUND AND/OR POLYMER, AND ORGANIC THIN FILM DEVICE AND ORGANIC THIN FILM TRANSISTOR EACH COMPRISING THE ORGANIC THIN FILM

#57
20100324093
2010-12-23

CCR9 INHIBITORS AND METHODS OF USE THEREOF

#58
20100280250
2010-11-04

THERAPEUTIC AND DELIVERY METHODS OF PROSTAGLANDIN EP4 AGONISTS

#59
20100280074
2010-11-04

CCR9 inhibitors and methods of use thereof

#60
20100234350
2010-09-16

Platelet ADP receptor inhibitors

#61
20100227898
2010-09-09

Microbiocides

#62
20100222389
2010-09-02

Microbiocides

#63
20100184766
2010-07-22

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

#64
20100105894
2010-04-29

Cyclopropane compounds and pharmaceutical use thereof

#65
20100093802
2010-04-15

CCR9 inhibitors and methods of use thereof

#66
20100069378
2010-03-18

SUBSTITUTED INDANYL SULFONAMIDE COMPOUNDS, THEIR PREPARATION AND USE AS MEDICAMENTS

#67
20100048669
2010-02-25

Therapeutic compounds

#68
20100048549
2010-02-25

Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4

#69
20100029609
2010-02-04

BIARYL SULFONAMIDE DERIVATIVES

#70
20100004339
2010-01-07

Somatostatin Receptor 1 and/or 4 Selective Agonists and Antagonists

#71
20090325962
2009-12-31

TYROSINE DERIVATIVE

#72
20090299074
2009-12-03

BENZO[b]THIOPHEN DERIVATIVES AND PROCESS FOR THEIR PRODUCTION

#73
20090270396
2009-10-29

Therapeutic compounds

#74
20090261300
2009-10-22

Heteroacene derivative, tetrahaloterphenyl derivative, and processes for producing the same

#75
20090247536
2009-10-01

Bissulfonamide Compounds As Agonists Of GalR1, Compositions, And Methods Of Use

#76
20090227667
2009-09-10

Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof

#77
20090227585
2009-09-10

SUBSTITUTED N-HETEROCYCLE DERIVATIVES AND METHODS OF THEIR USE

#78
20090215780
2009-08-27

Preparation and Use of Aryl Alkyl Acid Derivatives for the Treatment of Obesity

#79
20090215764
2009-08-27

Antimicrobial agents

#80
20090209532
2009-08-20

PHARMACEUTICAL COMPOUNDS

#81
20090192213
2009-07-30

Benzo[b]furane And Benzo[b]thiophene Derivatives

#82
20090170907
2009-07-02

Chemical Compounds

#83
20090163547
2009-06-25

Indene derivatives, their preparation and use as medicaments

#84
20090131433
2009-05-21

Histamine-3 receptor antagonists

#85
20090093485
2009-04-09

Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases

#86
20090087409
2009-04-02

Viral polymerase inhibitors

#87
20090054495
2009-02-26

CCR9 inhibitors and methods of use thereof

#88
20090054235
2009-02-26

Benzoheterocyclylethylbenzamide derivatives

#89
20090048224
2009-02-19

COMPOUNDS AND METHODS OF USE

#90
20090030038
2009-01-29

Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 Receptor

#91
20090023918
2009-01-22

PROCESS FOR PREPARING 3-ACYLAMINOBENZOFURAN-2-CARBOXYLIC ACID DERIVATIVE

#92
20090012093
2009-01-08

Receptor function regulator

#93
20080306258
2008-12-11

Cyclopropane compounds and pharmaceutical use thereof

#94
20080300269
2008-12-04

Therapeutic compounds

#95
20080261994
2008-10-23

CYCLOPROPANE COMPOUNDS AND PHARMACEUTICAL USE THEREOF

#96
20080200461
2008-08-21

MODULATORS OF ACETYL-COENZYME A CARBOXYLASE AND METHODS OF USE THEREOF

#97
20080194597
2008-08-14

Platelet ADP receptor inhibitors

#98
20080167348
2008-07-10

Sulfonamide derivatives

#99
20080146623
2008-06-19

Inhibitors of histone deacetylase and prodrugs thereof

#100
20080119538
2008-05-22

Therapeutic compounds

#101
20080119513
2008-05-22

Sulfonamide Derivative Selectively Inhibiting Mmp-13

#102
20080103180
2008-05-01

CCR9 inhibitors and methods of use thereof

#103
20080085891
2008-04-10

Asthma and allergic inflammation modulators

#104
20080045483
2008-02-21

Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes

#105
20080027073
2008-01-31

Substituted indanyl sulfonamide compounds, their preparation and use as medicaments

#106
20080015219
2008-01-17

THERAPEUTIC COMPOUNDS

#107
20070299107
2007-12-27

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

#108
20070293561
2007-12-20

Therapeutic compounds

#109
20070259877
2007-11-08

Piperazine derivatives useful for the treatment of gastrointestinal disorders

#110
20070254929
2007-11-01

Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof

#111
20070232660
2007-10-04

THERAPEUTIC AND DELIVERY METHODS OF PROSTAGLANDIN EP4 AGONISTS

#112
20070213316
2007-09-13

N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives

#113
20070142333
2007-06-21

CYCLOALKYL INHIBITORS OF POTASSIUM CHANNEL FUNCTION

#114
20070129422
2007-06-07

Somatostatin receptor 1 and/or 4 selective agonists and antagonists

#115
20070066823
2007-03-22

CCR9 inhibitors and methods of use thereof

#116
20070010495
2007-01-11

10-hydroxy-11-dihydroprostaglandin analogs as selective EP4 agonists

#117
20070004787
2007-01-04

4-substituted and 7-substituted indoles, benzofurans, benzothiophenes, benzimidazoles, benzoxazoles, and benzothiazoles and methods for making same

#118
20060293306
2006-12-28

Viral polymerase inhibitors

#119
20060287386
2006-12-21

Benzo[b]furane and benzo[b]thiophene derivatives

#120
20060247215
2006-11-02

Cyclohexyl prostaglandin analogs as EP-receptor agonists

#121
20060223829
2006-10-05

Hydroxysteroid dehydrogenase inhibitors

#122
20060217433
2006-09-28

Sulfonamide derivatives as PPAR modulators

#123
20060199826
2006-09-07

Cyclopropane compounds and pharmaceutical use thereof

#124
20060194795
2006-08-31

Platelet ADP receptor inhibitors

#125
20060173188
2006-08-03

Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative

#126
20060173035
2006-08-03

3-aryloxy/thio-2,3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake

#127
20060167251
2006-07-27

CCR9 inhibitors and methods of use thereof

#128
20060160798
2006-07-20

Viral polymerase inhibitors

#129
20060135770
2006-06-22

PARP inhibitors

#130
20060116408
2006-06-01

N-substituted benzothiophenesulfonamide derivatives

#131
20060111430
2006-05-25

2,3,4-substituted cyclopentanones as therapeutic agents

#132
20060106089
2006-05-18

Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use

#133
20060106088
2006-05-18

2,3,4-substituted cyclopentanones as therapeutic agents

#134
20060069037
2006-03-30

Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors

#135
20060030606
2006-02-09

Cyclohexyl prostaglandin analogs as EP-receptor agonists

#136
20060030543
2006-02-09

Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease

#137
20050267152
2005-12-01

Gly1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders

#138
20050256180
2005-11-17

Substituted pyrazolyl compounds for the treatment of inflammation

#139
20050250959
2005-11-10

Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds

#140
20050234106
2005-10-20

Cycloalkyl inhibitors of potassium channel function

#141
20050228185
2005-10-13

10-Hydroxy-11-dihydroprostaglandin analogs as selective EP4 agonists

#142
20050228029
2005-10-13

Platelet ADP receptor inhibitors

#143
20050227959
2005-10-13

Heterocyclic compound having oxime group

#144
20050215548
2005-09-29

Bisarylsulfonamide compounds and their use in cancer therapy

#145
20050187251
2005-08-25

Substituted N-heterocycle derivatives and methods of their use

#146
20050164992
2005-07-28

Treatment of inflammatory bowel disease

#147
20050130221
2005-06-16

Synthesis for the preparation of compounds for screening as potential tubulin binding agents

#148
20050124654
2005-06-09

Compounds and methods of use

#149
20050049227
2005-03-03

Cyclohexyl prostaglandin analogs as EP-receptor agonists

#150
20050043304
2005-02-24

Novel amine derivative having human beta-tryptase inhibitory activity and drugs containing the same